These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3891282)

  • 41. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
    Cooper CE; Slocombe B; White AR
    J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients.
    Schaad UB; Casey PA; Cooper DL
    Antimicrob Agents Chemother; 1983 Feb; 23(2):252-5. PubMed ID: 6838187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Augmentin].
    Foster M
    Antibiot Khimioter; 1992 Sep; 37(9):3-9. PubMed ID: 1444667
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparative study of cephradine and amoxicillin-clavulanate in the treatment of recurrent urinary tract infections.
    Brumfitt W; Hamilton-Miller JM
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1803-5. PubMed ID: 2285294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Miyachi Y; Ueda S; Hayakawa F; Nakashima T; Hakamada S; Kuno K
    Jpn J Antibiot; 1985 Feb; 38(2):423-30. PubMed ID: 4009951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential sensitivities to amoxycillin/clavulanate and amoxycillin in general practice urinary infections.
    Brumfitt W; Hamilton-Miller JM
    Lancet; 1983 Sep; 2(8349):566. PubMed ID: 6136712
    [No Abstract]   [Full Text] [Related]  

  • 47. [Laboratory and clinical studies on BRL 25000 (clavulanic acid -amoxicillin) granules in the pediatric field].
    Cho K; Sakata H; Fujita K; Yoshioka H; Mukai N
    Jpn J Antibiot; 1985 Feb; 38(2):253-62. PubMed ID: 4009947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Augmentin--current and prospective therapeutic indications].
    Mihălţan F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(3):203-10. PubMed ID: 2855664
    [No Abstract]   [Full Text] [Related]  

  • 49. Activities of amoxicillin and clavulanic acid combinations against urinary tract infections.
    Crokaert F; van der Linden MP; Yourassowsky E
    Antimicrob Agents Chemother; 1982 Aug; 22(2):346-9. PubMed ID: 6765418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of gonorrhea with clavulanate-potentiated amoxicillin (Augmentin).
    Munday PE; Bingham JS; Ison CA; Erdman YJ; Harris JR; Easmon CS
    Sex Transm Dis; 1985; 12(3):163-5. PubMed ID: 3929409
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase].
    Prát V; Horcicková M; Hatala M; Liska M; Matousovic K
    Cas Lek Cesk; 1985 Jun; 124(23):711-4. PubMed ID: 3874692
    [No Abstract]   [Full Text] [Related]  

  • 52. [Antimicrobial activities of clavulanic acid/amoxicillin against freshly isolated clinical strains from outpatients].
    Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1995 Dec; 48(12):1920-34. PubMed ID: 8587166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Sato Y; Iwata S; Akita H; Murai T; Ibara M; Oikawa T; Osano M
    Jpn J Antibiot; 1985 Feb; 38(2):327-41. PubMed ID: 3847521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amoxycillin clavulanate: an assessment after 15 years of clinical application.
    Ball P; Geddes A; Rolinson G
    J Chemother; 1997 Jun; 9(3):167-98. PubMed ID: 9210001
    [No Abstract]   [Full Text] [Related]  

  • 55. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Sunakawa K; Ishizuka Y
    Jpn J Antibiot; 1985 Feb; 38(2):319-26. PubMed ID: 3892075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The development of bacterial resistance and the role of clavulanic acid].
    Rolinson JN
    Antibiot Khimioter; 1992 Sep; 37(9):11-4. PubMed ID: 1444658
    [No Abstract]   [Full Text] [Related]  

  • 57. Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.
    Thornley PE; Aitken JM; Nichol GM; Slevin NJ
    Drugs; 1986; 31 Suppl 3():113-4. PubMed ID: 3525087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Todd PA; Benfield P
    Drugs; 1990 Feb; 39(2):264-307. PubMed ID: 2184003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
    Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical experience with BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
    Nagata K; Yokoyama M
    Jpn J Antibiot; 1985 Feb; 38(2):263-8. PubMed ID: 4009948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.